Portfolio company
giinnovation
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotechnology firm develops protein-based therapeutics and immuno-oncology drugs for pharmaceutical partners and patients with cancer or allergic diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Infinimmune
This biotechnology company develops human-derived antibody therapeutics for pharmaceutical partners and patients with atopic dermatitis and other inflammatory diseases.
Genome&Co
This company develops microbiome-based therapeutics and novel antibody drugs for pharmaceutical partners and patients with cancer or skin diseases.
Allorion
This biotechnology company develops small-molecule drugs for patients with cancer and autoimmune diseases using its proprietary drug discovery platforms.
Imagene
This clinical-stage biotechnology company develops therapeutics for patients with immunological, autoimmune and inflammatory diseases to improve quality of life.
Genevation
This biotechnology company develops personalised mRNA cancer vaccines and therapeutics using artificial intelligence for patients requiring precision oncology treatments.
ybiologics
The company develops antibody-based therapeutics and immuno-oncology drugs for pharmaceutical partners and the global healthcare sector.
immunos
This biotechnology company develops immunomodulatory proteins and HLA-based biologic therapies for pharmaceutical companies and healthcare providers to treat cancer and autoimmune diseases.
Cellemedy
The company develops next-generation protein therapeutics and immuno-oncology drugs for patients suffering from cancer.
